KRP-AM1977X PhaseIII Clinical Study-Open-label study for the patients with respiratory tract infection

Kyorin Pharmaceutical Co.,LTD0 个研究点目标入组 53 人开始时间: 2015年5月25日最近更新: 2023年10月17日

适应症

试验速览

阶段: 3 期
状态: 已完成
发起方: Kyorin Pharmaceutical Co.,LTD
入组人数: 53

研究概览入排标准研究者记录与标识符相似试验

研究概览

简要总结

KRP-AM1977X was highly effective for both secondary infection of chronic respiratory disease and acute bronchitis. In the safety assessment, no major problem was observed in KRP-AM1977X.

研究设计

研究类型: Interventional

入排标准

年龄范围: >= 16age old 至 ot applicable（—）
性别: All

入选标准

•Respiratory tract infection with clear infection symptoms

排除标准

•Patient with severe infection
•Patient with serious functional disorder that would unsuitable for the study
•Patient showing the tendency to improve pneumonia symptoms by other agents

研究者

发起方

Kyorin Pharmaceutical Co.,LTD

相似试验

已完成

3 期

A Phase III , open-label study of KRP-AM1977Y in respiratory tract infectio

JPRN-jRCT2080223247Kyorin Pharmaceutical Co.,LTD78

已完成

3 期

Open-label study for the patients with otorhinolaryngological infection

JPRN-jRCT2080222863Kyorin Pharmaceutical Co.,LTD70

已完成

3 期

KRP-AM1977X Phase III Comparative Study (sinusitis)Sinusitis (severity of infection: moderate to severe)

JPRN-jRCT2080222862Kyorin Pharmaceutical Co.,LTD279

已完成

3 期

KRP-AM1977X Phase III Comparative Study (Community acquired pneumonia)

JPRN-jRCT2080222860Kyorin Pharmaceutical Co.,LTD277

已完成

1 期

Phase I study of KRP-AM1977X (Clinical pharmacological study)Japanese healthy adult male subjects

JPRN-jRCT2080225163Kyorin Pharmaceutical Co., Ltd.54